Two patients presenting IgA nephropathy after COVID-19 vaccination during a follow-up for asymptomatic hematuria무증상 혈뇨 추적관찰 중 코로나19 예방접종 후 IgA 신병증을 보인 2명의 환자Case Reports Published on 2022-07-012022-09-12 Journal: Pediatric Nephrology (Berlin, Germany) [Category] MERS, 진단, [키워드] Asymptomatic COVID-19 vaccination Follow-up Hematuria IgA nephropathy presenting Two patient [DOI] 10.1007/s00467-022-05518-0 PMC 바로가기 [Article Type] Case Reports
Association Between Total Cell Free DNA and SARS-CoV-2 In Kidney Transplant Patients: A Preliminary StudyArticle Published on 2022-07-012022-11-15 Journal: Transplantation proceedings [Category] COVID19(2023년), SARS, 바이오마커, [키워드] association Biomarker blood sample cell-free DNA cellular cfDNA collected COVID-19 COVID-19 diagnosis COVID-19 severity Cutoff DNA elevated examined Follow-up fraction Fractions Free high risk Hospitalized identify immune response Immunosuppression Infection Interpretation lowering median patients patients with COVID-19 positive R 2 raise recipient rejection reported Retrospective analysis risk SARS-CoV-2 severe COVID-19 significant decrease subset the median Total Transplant Two patient with COVID-19 [DOI] 10.1016/j.transproceed.2022.02.027 PMC 바로가기
Traditional Vietnamese medicine Kovir capsule in patients with mild COVID-19: A double-blind randomized controlled trialRandomized Controlled Trial Published on 2022-07-012022-10-04 Journal: Phytotherapy research : PTR [Category] Coronavirus, COVID19(2023년), SARS, 임상, [키워드] adverse events clearance conducted COVID-19 decrease discharge disease double-blind double-blind study Efficacy evaluate Herbal IMPROVE in both group Mild mild COVID-19 patients outcome Patient patients PCR-confirmed Placebo placebo-controlled progression Randomized Randomized controlled trial recruited required respiratory infections Safe Safety SARS-CoV-2 severe COVID-19 significantly lower Symptom symptom resolution Symptoms the placebo group Traditional Traditional medicine Treatment Trial two groups Two patient viral clearance Viral load [DOI] 10.1002/ptr.7455 PMC 바로가기 [Article Type] Randomized Controlled Trial
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients혈청 음성 입원 환자에서 우려 일치 COVID-19 회복기 혈장 사용의 변형Article Published on 2022-06-302022-09-11 Journal: Viruses [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] 28-day mortality advanced disease Adverse reaction Adverse reactions affecting age anti-spike monoclonal antibodies anti-spike monoclonal antibody Anti-viral therapy Blood donors CCP collected convalescent convalescent plasma COVID-19 COVID-19 convalescent plasma Delta Efficacy hospital Hospitalized hospitalized COVID-19 patient hospitalized patient Immunocompromised Immunocompromised patient Immunocompromised patients infused IQR Italian mAb mAbs median age mortality rate NAbs Neutralizing antibodies neutralizing antibody omicron outcome patients protective immune response Randomized controlled trial recipient reported rescued SARS-CoV-2 seronegative severe COVID-19 Support Two patient two patients Usage variants variants of concern VoC VOCs were recorded [DOI] 10.3390/v14071443 PMC 바로가기 [Article Type] Article
Safety of biological therapy in children and adolescents with severe asthma during the COVID-19 pandemic: a case seriesArticle Published on 2022-06-062022-11-15 Journal: Acta bio-medica : Atenei Parmensis [Category] COVID19(2023년), SARS, 진단, [키워드] allergic Asthma Asymptomatic disease biologic case sery children Clinical characteristics Clinical features collected data Comorbidities control group COVID-19 COVID-19 pandemic demographic data described disease enrolled greater groups Hospitalization Infection Laboratory lack Mild obesity outcome Patient patients patients treated pediatric Pediatric patient positive required Result risk Safety SARS-CoV-2 severe COVID-19 severity tested the disease the SARS-CoV-2 Therapies therapy treated Treatment Two patient [DOI] 10.23750/abm.v93iS3.13073 PMC 바로가기
SARS-CoV-2 in saliva, viremia and seroprevalence for COVID-19 surveillance at a single hematopoietic stem cell transplantation center: a prospective cohort study단일 조혈모세포 이식 센터에서 COVID-19 감시를 위한 타액, 바이러스혈증 및 혈청 유병률에 대한 SARS-CoV-2: 전향적 코호트 연구Article Published on 2022-06-062022-09-11 Journal: Revista do Instituto de Medicina Tropical de São [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] addition adopted allogeneic HSCT anti-SARS-CoV-2 anti-SARS-CoV-2 IgG Asymptomatic Brazil COVID-19 dentist dentists FIVE healthcare healthcare worker Healthcare workers Hematopoietic stem cell HSCT Nurse Nurses pandemic Patient plasma plasma sample plasma samples positive positive RT-PCR positive serology Prevalence prospective cohort study protocol Result Saliva sample collection SARS-CoV-2 Seroconversion Seroprevalence Seven stem cell Stem cell transplantation Surveillance tested Two patient two patients Viral Viral detection viral shedding Viremia was performed [DOI] 10.1590/S1678-9946202264039 PMC 바로가기 [Article Type] Article
Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trialClinical Trial Published on 2022-06-012022-10-05 Journal: Enfermedades infecciosas y microbiologia clinica ( [Category] COVID19(2023년), SARS, 임상, [키워드] 95%CI Admission asked benefit both groups clinical symptom Comorbidities contraindication Control control group COVID-19 decrease diarrhea died Disease progression Efficacy and safety English female FIVE Follow-up HCQ Health Health care worker Healthcare professional healthcare worker Healthcare workers Hidroxicloroquina Hospitalization Hydroxychloroquine in both groups in viral Infección por SARS-CoV-2 initial intensive care unit Loading dose media median age Mild mild SARS-CoV-2 infection Negative conversion no significant difference non-randomized non-randomized trial outcome outpatients Pacientes externos Patient PCR Pneumonia primer Probability professional Prospective prospectivo reduction in required SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 viral load Side effect significant difference Spanish Symptom Trabajadores sanitarios. Treatment treatment group Two patient viral dynamics were given [DOI] 10.1016/j.eimce.2020.10.015 PMC 바로가기 [Article Type] Clinical Trial
Evolution of pathological findings in surveillance biopsies of lung transplant recipients infected with SARS-CoV-2SARS-CoV-2에 감염된 폐 이식 수혜자의 감시 생검에서 병리학적 소견의 진화Article Published on 2022-06-012022-09-11 Journal: Transplant infectious disease : an official journa [Category] COVID19(2023년), SARS, 치료기술, 치료법, [키워드] Admission alteration biopsy Bronchiolitis bronchiolitis obliterans case sery coronavirus disease Coronavirus disease 2019 COVID-19 described determine Diagnosis died Evolution Follow-up GRADE heart histology Hospitalized ICU immunofluorescence inclusion criteria infected with SARS-CoV-2 intensive care intensive care unit large cohort lung Lung injury lung transplant lung transplantation non-transplant patient non-transplant patients one patient Organizing pneumonia outcome outcomes pathologic pathological finding pathology Patient positive Prognosis Protein recipient recipients rejection respiratory pathogen SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleocapsid Society specimen subset Surveillance Symptomatic patients tested transbronchial Transplant Two patient two patients was performed [DOI] 10.1111/tid.13823 PMC 바로가기 [Article Type] Article
The use of the faecal immunochemical test during the COVID-19 pandemic to triage urgent colorectal cancer referralsObservational Study Published on 2022-06-012022-10-04 Journal: Colorectal disease : the official journal of the A [Category] 임상, [키워드] Cancer Colorectal cancer COVID-19 pandemic criteria CT scanning demographic detection rate England First wave fit FIT screening Guidance immunochemical in both group investigated median age National National Health Service pandemic pathway Patient reduced reducing reduction in Safe significant increase suggested Symptoms Two patient urgent suspected cancer triage. Viral transmission [DOI] 10.1111/codi.16120 PMC 바로가기 [Article Type] Observational Study
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies항암치료를 받는 환자의 코로나19 백신접종에 대한 항체 및 T세포 반응Article Published on 2022-06-012022-09-11 Journal: Journal for immunotherapy of cancer [Category] COVID19(2023년), MERS, SARS, 바이오마커, 변종, 진단, 치료기술, 치료제, [키워드] active treatment adrenal crisis Adrenal insufficiency Affect Anti-CD20 antibodies Anti-CD20 antibody Anti-viral antibodies antibody antibody formation Antibody titer Antibody titers Anticancer therapy B cells B-cell B.1.617.2 blockade Cancer CD4 CD8 Cell cellular Chemoimmunotherapy Chemotherapy Corticosteroids COVID-19 COVID-19 infection COVID-19 infections COVID-19 vaccination COVID-19 vaccinations COVID-19 vaccine trials cross-reactive cytokine detectable develop dose doses effector cells Endocrine expressed follicular generate healthy donor healthy donors helper cells Humoral response hypoadrenalism Hypothesis IgG antibody titer immune Immunocompromised immunogenic immunogenicity immunogenicity, vaccine Immunotherapy intracellular cytokine staining Lymphocytes mRNA vaccine Multiple myeloma Myeloma n=36 no differences oncology patients Participants Patient Patients with cancer PD-1 peptide peptides Phase 3 profile Prophylactic RBD reactivity receiving Receptor binding domain Safe seronegative seronegative patient Side effect solid tumors spike Spike protein steroid Steroids Stress symptomatic T cell T cell response T cell responses T cells T follicular helper cells T-lymphocytes targeted therapy the SARS-CoV-2 therapy Treatment treatment groups tumors Two patient two patients vaccination Vaccinations Vaccine variant spike was measured were assessed were excluded wild-type WT spike [DOI] 10.1136/jitc-2022-004766 PMC 바로가기 [Article Type] Article